Author Topic: (AAN abst.) Early vs. later treatment start in MS: A register-based cohort study (Denmark)  (Read 160 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
Presented at the annual AAN conference, April 24-27, 2018--"Early versus Later Treatment Start in Multiple Sclerosis -   A Register Based Cohort Study" by T. Chalmer et al. of the Danish MS Registry, Department of Neurology, Rigshospitalet, Denmark--and discussed in this article in MS News Today (April 18, 2018):

https://multiplesclerosisnewstoday.com/2018/04/18/early-ms-treatment-delays-progression-danish-study/?utm_source=Multiple+Sclerosis&utm_campaign=18cd9e43a5-RSS_US_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-18cd9e43a5-71286581

:



« Last Edit: May 18, 2018, 03:16:00 pm by agate »
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
115 Views
Last post June 16, 2017, 08:15:39 am
by agate
0 Replies
93 Views
Last post November 10, 2017, 10:52:57 am
by agate
1 Replies
146 Views
Last post March 04, 2019, 09:36:37 pm
by agate
0 Replies
23 Views
Last post December 02, 2021, 09:15:53 pm
by agate
0 Replies
16 Views
Last post March 09, 2023, 03:33:20 pm
by agate